Wnt16 Increases Bone-to-Implant Contact in an Osteopenic Rat Model by Increasing Proliferation and Regulating the Differentiation of Bone Marrow Stromal Cells

• Published in: Annals of biomedical engineering 2024-06, Vol.52 (6), p.1744-1762
• Main Authors: Berger, Michael B., Bosh, Kyla, Deng, Jingyao, Jacobs, Thomas W., Cohen, D. Joshua, Boyan, Barbara D., Schwartz, Zvi
• Format: Article
• Language: English
• Subjects: Animal models; Animals; Antibodies; Biochemistry; Biological and Medical Physics; Biomedical and Life Sciences; Biomedical Engineering and Bioengineering; Biomedicine; Biophysics; Bone Diseases, Metabolic - metabolism; Bone Diseases, Metabolic - pathology; Bone growth; Bone implants; Bone marrow; Bone remodeling; Botulinum toxin; Cancellous bone; Cell Differentiation; Cell proliferation; Cell Proliferation - drug effects; Cells, Cultured; Classical Mechanics; Cortical bone; Differentiation; Disease Models, Animal; Male; Mechanical properties; Mesenchymal Stem Cells - cytology; Mesenchymal Stem Cells - metabolism; Morphology; Original Article; Osseointegration; Osseointegration - drug effects; Osteoblastogenesis; Osteoblasts; Osteoclasts; Osteogenesis; Osteoprogenitor cells; Osteoprotegerin; Rats; Rats, Sprague-Dawley; Regeneration; Regeneration (physiology); Signal transduction; Stromal cells; Substrates; Surface properties; Titanium; Transplants & implants; Wnt protein; Wnt Proteins - metabolism
• ISSN: 0090-6964; 1573-9686
• DOI: 10.1007/s10439-024-03488-y

Osseointegration is a complex biological cascade that regulates bone regeneration after implant placement. Implants possessing complex multiscale surface topographies augment this regenerative process through the regulation of bone marrow stromal cells (MSCs) that are in contact with the implant surface. One pathway regulating osteoblastic differentiation is Wnt signaling, and upregulation of non-canonical Wnts increases differentiation of MSCs on these titanium substrates. Wnt16 is a non-canonical Wnt shown to regulate bone morphology in mouse models. This study evaluated the role of Wnt16 during surface-mediated osteoblastic differentiation of MSCs in vitro and osseointegration in vivo. MSCs were cultured on Ti substrates with different surface properties and non-canonical Wnt expression was determined. Subsequently, MSCs were cultured on Ti substrates +/−Wnt16 (100 ng/mL) and anti-Wnt16 antibodies (2 μg/mL). Wnt16 expression was increased in cells grown on microrough surfaces that were processed to be hydrophilic and have nanoscale roughness. However, treatment MSCs on these surfaces with exogenous rhWnt16b increased total DNA content and osteoprotegerin production, but reduced osteoblastic differentiation and production of local factors necessary for osteogenesis. Addition of anti-Wnt16 antibodies blocked the inhibitor effects of Wnt16. The response to Wnt16 was likely independent of other osteogenic pathways like Wnt11-Wnt5a signaling and semaphorin 3a signaling. We used an established rat model of cortical and trabecular femoral bone impairment following botox injections (2 injections of 8 units/leg each, starting and maintenance doses) to assess Wnt16 effects on whole bone morphology and implant osseointegration. Wnt16 injections did not alter whole bone morphology significantly (BV/TV, cortical thickness, restoration of trabecular bone) but were effective at increasing cortical bone-to-implant contact during impaired osseointegration in the botox model. The mechanical quality of the increased bone was not sufficient to rescue the deleterious effects of botox. Clinically, these results are important to understand the interaction of cortical and trabecular bone during implant integration. They suggest a role for Wnt16 in modulating bone remodeling by reducing osteoclastic activity. Targeted strategies to temporally regulate Wnt16 after implant placement could be used to improve osseointegration by increasing the net pool of osteoprogenitor cells.